ArticleMaterials today. Bio2026
Preclinical evaluation of patient-specific 3D-printed PDLLA/SrHAp implants in a minipig segmental mandibular defect model.
Article in Materials today. Bio, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
16 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Large segmental mandibular defects remain difficult to reconstruct, and patient-specific biodegradable scaffolds produced by additive manufacturing may offer an alternative to permanent alloplastic implants. This exploratory study evaluated three 3D-printed poly(DL-lactide) (PDLLA)-based implant configurations in a periosteum-preserving minipig mandibular defect model: PDLLA, PDLLA containing 10 wt% strontium-modified hydroxyapatite microparticles (PDLLA + SrHAp-P), and a biphasic PDLLA-shell/SrHAp-core implant (PDLLA/SrHAp-C). Twelve adult minipigs received patient-specific implants and titanium reconstruction plates (n = 4 per group). Bone formation was monitored by digital volume tomography and sequential fluorochrome labeling for 6 months; one animal per group underwent non-terminal follow-up to 14 months. Complications occurred in 11 of 12 animals and included dehiscence, abscess or fistula formation, implant swelling, screw loosening, and fracture or displacement of the SrHAp core. Bone bridging was radiographically observed in all animals by 6 months, including an animal in which the implant had been removed prematurely, indicating a major contribution of the preserved periosteum and host tissues. New bone formed mainly around, rather than within, the implants. Implant-associated bone ingrowth was observed only in the biphasic group, but was not a uniform finding and fibrous encapsulation was frequent. The 3 animals followed to 14 months showed continued consolidation without terminal sacrifice. These findings identify degradation-associated tissue reactions, dimensional instability, soft-tissue coverage, and construct mechanics as major limitations of large PDLLA-based mandibular implants. The biphasic architecture showed a potentially favorable local osteointegration pattern, but the small sample size and high complication rate preclude claims of efficacy or superiority. Further optimization of polymer content, ceramic architecture, porosity, mechanical stability, and soft-tissue management is required before additional translational studies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.